Kajuluri Lova Prasadareddy, Guo Yugene Young, Lee Sujin, Christof Michael, Malhotra Rajeev
Cardiovascular Research Center, Heart and Vascular Institute, Mass General Brigham, Boston, MA 02114, USA.
School of Arts and Sciences, University of Rochester, Rochester, NY 14627, USA.
Genes (Basel). 2025 Apr 28;16(5):506. doi: 10.3390/genes16050506.
Vascular diseases present a significant threat to human health worldwide. Atherosclerosis is the most prevalent vascular disease, accounting for the majority of morbidity and mortality globally. Vascular calcification is a dynamic pathological process underlying the development of atherosclerotic plaques and involves the phenotypic transformation of vascular smooth muscle cells (VSMCs) into osteogenic cells. Specifically, the phenotypic switch in VSMCs often involves modifications in gene expression due to epigenetic changes, including DNA methylation, histone modification, and non-coding RNAs. Understanding the role of these epigenetic changes in regulating the pathophysiology of vascular calcification, along with the proteins and pathways that mediate these changes, will aid in identifying new therapeutic candidates to enhance vascular health. This review discusses a comprehensive range of epigenetic modifications and their implications for vascular health and the development of vascular calcification.
血管疾病对全球人类健康构成重大威胁。动脉粥样硬化是最常见的血管疾病,在全球发病率和死亡率中占大多数。血管钙化是动脉粥样硬化斑块形成过程中的一个动态病理过程,涉及血管平滑肌细胞(VSMCs)向成骨细胞的表型转变。具体而言,VSMCs的表型转换通常涉及由于表观遗传变化导致的基因表达改变,包括DNA甲基化、组蛋白修饰和非编码RNA。了解这些表观遗传变化在调节血管钙化病理生理过程中的作用,以及介导这些变化的蛋白质和信号通路,将有助于识别增强血管健康的新治疗靶点。本综述讨论了一系列全面的表观遗传修饰及其对血管健康和血管钙化发展的影响。